SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193805-13-000878
Filing Date
2013-05-02
Accepted
2013-05-02 16:36:03
Documents
1
Group Members
BLOOMFIELD PARTNERS LPMSMB CAPITAL MANAGEMENT, LLCMSMB HEALTHCARE INVESTORS LLCMSMB HEALTHCARE LPMSMB HEALTHCARE MANAGEMENT LLCPOMPEII MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 e610875_13da-shkreli.htm SC 13D/A 339024
  Complete submission text file 0001193805-13-000878.txt   340582
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300
AMAG PHARMACEUTICALS INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-38286 | Film No.: 13808572
SIC: 2834 Pharmaceutical Preparations

Mailing Address 330 MADISON AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address
Shkreli Martin (Filed by) CIK: 0001525354 (see all company filings)

Type: SC 13D/A